Portsylis Vaccine Inactivated AR-T

Composition

The vaccine is made from detoxified dermonecrotic toxin Pasteurella multocida (protein dO) and inactivated Bordetella bronchiseptica microbial cells inactivated by formaldehyde.

Dosage form

Suspension for injection.

Method of administration

The vaccine is injected intramuscularly into the parotid region in a volume of 2 ml.

Form of issue

The vaccine is packaged in 20 ml (10 doses), 50 ml (25 doses) or 100 ml (50 doses) in glass or plastic bottles of appropriate capacity.

Storage conditions

Shelf life of the vaccine is 5 years from the date of manufacture, subject to storage and transportation conditions, at a storage temperature of 2 ° C to 8 ° C.

Biological properties

The vaccine causes the formation of an immune response to the causative agents of infectious atrophic rhinitis after a two-time application lasting 6 months, which is transmitted to offspring obtained from immunized parents. The vaccine is harmless, does not have medicinal properties.

The order of application

The vaccine is designed to immunize pigs against infectious atrophic rhinitis.

It is forbidden to vaccinate clinically ill and / or weakened animals.

Animals are immune from the age of 18 weeks of age. The vaccine is injected intramuscularly into the parotid region in a volume of 2 ml. Earlier not vaccinated pregnant sows and repair mumps vaccine is administered twice in the second half of pregnancy, with an interval of 2 weeks - 6 and 4 weeks before the expected farrowing. Revaccination of sows is carried out with a single dose of vaccine - in the second half of each pregnancy, 2-4 weeks before the expected farrowing. Before use, the vials with the vaccine are kept for 8-9 hours at room temperature (18 C - 22 C) and immediately before and during vaccination the vial is shaken thoroughly. The vaccine is administered in accordance with generally accepted rules of aseptic and antiseptic, the injection site is treated with 70 degree ethyl alcohol.

Symptoms of infectious atrophic atrophic rhinitis, as well as other pathological signs in case of an overdose of the vaccine is not established.

Features of postvaccinal reaction in primary immunization is not established.

If you miss the next injection of the vaccine, you should immunize as soon as possible. It is necessary to avoid violations of the scheme and the timing of vaccination, since this can lead to a decrease in the effectiveness of immunization of infectious atrophic rhinitis.

In some cases, there may be a slight swelling at the injection site of the drug, spontaneously disappearing within one to two weeks, as well as a short-term increase in temperature by 1.5C-2.5C, a decrease in activity and appetite on the day of vaccination. When using the vaccine in accordance with this instruction, side effects and complications are usually not noted.

It is forbidden to use the vaccine porphyles AR-T DF together with other immunobiological preparations.

The slaughter products from vaccinated animals are implemented without restriction, irrespective of the timing of vaccination.